INCY Latest Headlines

Analysts Conflicted on These Healthcare Names: Perspective Therapeutics (CATX), Bristol-Myers Squibb (BMY) and Incyte (INCY)

at www.tipranks.com (Fri, 16-Oct 9:50 PM)

Canaccord Genuity Sticks to Their Buy Rating for Incyte (INCY)

at www.tipranks.com (Thu, 15-Oct 7:36 AM)

Wells Fargo Remains a Hold on Incyte (INCY)

at www.tipranks.com (Thu, 15-Oct 7:36 AM)

Incyte Buy Rating Reiterated as KRAS G12D Asset Shows Differentiated Efficacy; $152 Price Target Maintained

at www.tipranks.com (Tue, 13-Oct 6:26 AM)

Analysts Conflicted on These Healthcare Names: 4D Molecular Therapeutics (FDMT), Pfizer (PFE) and Incyte (INCY)

at www.tipranks.com (Tue, 13-Oct 5:30 AM)

Barclays Keeps Their Buy Rating on Incyte (INCY)

at www.tipranks.com (Tue, 13-Oct 4:55 AM)

BMO Capital Keeps Their Hold Rating on Incyte (INCY)

at www.tipranks.com (Tue, 13-Oct 1:15 AM)

Syndax plummets as IPF asset axatilimab fails in phase 2 trial

at seekingalpha.com (Mon, 12-Oct 4:38 PM)